We recently hosted our quarterly team days in Cambridge, UK! Team days are a great opportunity for the full Healx team to get together and connect on our mission to transform the lives of individuals living with #rarediseases. During three action-packed days, we participated in a variety of workshops, shared our latest learnings and heard from our board members Jonathan Milner and our co-founder and chairman Dr. David Brown in a fireside chat. We're thankful for moments like these to collaborate under one roof, plan toward near-term goals, and celebrate our recent achievements together.
Healx
Biotechnology Research
Cambridge, Cambridgeshire 17,858 followers
AI-powered and patient-inspired. We accelerate the discovery and development of rare disease treatments.
About us
Healx is a mission-driven technology company pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are more than 10,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact.
- Website
-
http://www.healx.ai
External link for Healx
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Privately Held
- Founded
- 2014
Locations
-
Primary
66-68 Hills Rd
Charter House
Cambridge, Cambridgeshire CB21LA, GB
Employees at Healx
Updates
-
We're #hiring a new Business Development Senior Manager in Cambridge, England. Apply today or share this post with your network.
-
Our Chief Collaboration Officer Bruce Bloom participated in a round-table at the Global Genes 2024 RARE Advocacy Summit last week. Along with patient advocates and other industry peers, he discussed how drug developers can improve clinical trial feasibility through better engagement with #patientadvocacy organizations. Check out highlights from the event below!
-
October 1st is #CACNA1CAwareness Day, and we're joining Timothy Syndrome Alliance to help spread awareness for CACNA1C-related diseases and advocate for more research and treatment options for those affected by these diseases.
Today is #CACNA1C #AwarenessDay. Please show your support by sharing this post. We are hoping we can be loud all over the world. (This reel can be found in multiple languages on our YouTube account). CACNA1C-related disorders -> Are rare genetic disorders -> Affect an unknown number worldwide -> Can result in life-threatening health problems -> are often misdiagnosed -> currently have no cure TSA supports CACNA1C globally from the UK. We promote #research to understand how the gene changes cause symptoms and to develop therapies and treatments. CACNA1C-related disorders, including #TimothySyndrome and #LongQT8, are multisystemic and individuals found to have any CACNA1C gene change (including those with Variants of Uncertain Significance #VUS) should receive cardiac, developmental, psychiatric, endocrine (particularly diabetic) and neurological (epilepsy) screening. This however is currently not understood nor advocated for by key bodies including the National Health Service (NHS), something we are working on. For more information about our work please watch the latest film ‘Connections’ (found on our website, here and YouTube), a collaboration between the Timothy Syndrome Alliance (TSA) and Cardiff University / Prifysgol Caerdydd, we explore the importance of connections between individuals and families with lived experience of CACNA1C-related disorders (CRDs) and Timothy Syndrome (TS), academics, clinical teams and researchers. The more links we make, the stronger our network becomes and the faster we grow our understanding of our #raredisease. Without connections, we can't grow or learn. #RareDiseases #Awareness #calcium #ionchannels #channelopathies
-
Our Chief Collaboration Officer Bruce Bloom will be speaking at the Beacon for Rare Diseases Cambridge Rare Disease Showcase on 2nd October to discuss #AI development of #raredisease therapies. We're looking forward to sponsoring and speaking at this event which brings together industry experts, patient groups, and healthcare providers to share ideas, progress and achievements in rare diseases. Learn more about #RareShowcase24 here: https://lnkd.in/eHw5xhGd
-
At Healx, we are true believers that every rare disease patient deserves treatment. That's why our first company value is "care for rare". Every day, we strive to turn this value into action by leveraging cutting-edge #AI technology to accelerate the discovery of life-changing therapies for the #raredisease community. Dive into this company value below, and learn more about who we are here: https://healx.ai/about/
-
We're thrilled to have received the Life Science AI award at the 34th #BusinessWeeklyAwards! This award reflects our team's dedication to revolutionizing #raredisease treatment through cutting-edge AI-driven drug discovery. Thank you to our team members and partners who helped make this possible, and to BusinessWeekly newspaper for a wonderful evening and for recognizing our mission to make a positive difference to rare disease patients and their families. L-R: Guest speaker Dr Hermann Hauser, Tim Guilliams, David Brown and Barnaby Perks, CEO of sponsoring company St John's Innovation Centre Ltd Photo: Phil Mynott - www.philmynottphoto.co.uk
-
Our Scientific Associate Director Phil Brownjohn will be giving two poster presentations at Cilia2024, the world’s largest scientific meeting for cilia and flagella research. We're excited to share our research at the event and learn more about the recent developments in #cilia and #ciliopathy research. Learn more about the event here: https://cilia2024.ie/
-
The future of #drugdiscovery is here, and it's powered by AI. At Healx, we utilize #AI to develop new treatments for #rarediseases. Not only can the use of AI help reduce costs and timelines, it can open the doors for greater scalability, thus reaching a broader patient population. Read more about the power of AI in #biotech in this article from The Times.
-
Healx reposted this
I just read a truly inspiring post from my dear friend, Dr Jack Kreindler, describing the parallels between Michelangelo’s ‘David’ and the battles we face in Biotech. In the fight against rare diseases, it's even more the case. We often feel like David going up against Goliath. The challenges are immense, and the odds can seem overwhelming. But as Michelangelo’s ‘David’ teaches us, true innovation often comes from the most unexpected places. At Healx, we’re on a relentless quest to discover new medicines for those who need them most—patients with rare diseases who have long been overlooked. 95% of rare diseases don't have an approved treatment today. Our weapon of choice in this battle? AI-driven drug discovery. Just as David used his slingshot with precision, we use advanced AI to pinpoint and develop treatments with unparalleled accuracy, targeting the very roots of complex diseases. Rare diseases represent one of the greatest unmet needs in medicine, with over 300 million patients around the world still waiting for effective treatments. But with every breakthrough, every step forward, we’re proving that even the smallest, most focused efforts can make a world of difference. Together, we’re carving out a new path in healthcare—one that stands tall against the giants of the industry, not by sheer size or force, but by innovation, passion, and a commitment to those who have been forgotten for too long. #RareDiseases #AI #Biotech #Innovation #DavidVsGoliath #DrJack
Physician & Explorer. Founder, CEO @WellFounded. Researching the limits of human performance & healthy longevity.
What can Michelangelo’s ‘David’ teach us about the battles hard-fought by #Biotech to beat the Goliaths of #Pharma? Little did I know that, at the time, Michelangelo was just a 26 when he fought to win the commission to sculpt this herculean monolith of David - as one of 12 biblical prophets to adorn and support the base of Brunelleschi’s legendary and still the world’s largest brick Dome of Florence Cathedral, itself a 129 year Phase 1 symbol of defiance by the free Florentine Republic against the Medici’s all powerful and encircling presence. It was 523 years ago. 1501. He took a deep breath and raised his hand. Michelangelo was up against the greatest, most influential sculptors of the era. Donatello, Duccio, Agostino, Bandinelli, Sansovino and even the great Leonardo da Vinci were consulted. The Vatican and Republic’s Counsel of 12 favoured his bold vision. The luck he created for himself followed by 2 years of painstaking application of genius was ground breaking. So striking and exceptional was this work that once finished in 1504 it had to be protected from destruction from those who saw for what it actually was, an icon of poised confidence with simple but lethal weaponary against the giants of the era. The weaponary being the power of democracy and freedom to innovate. David is to the world of artistic expression and political symbolism what antibiotics are to medicine. We’re habituated to both now. We walk past David just like we pop 500mg of Penicillin often without realising how much the world changed since. The metaphor for medicine is profound. Like a bold new venture backed ecosystem the Republic fought for, often to the death, to earn its independence disrupting the conservative rule of those preserving their industrial and political control. Yet even among this new innovation economy there was fierce competition between startups and founders established and new comers. It was not just tenacity and talent that led Michelango to succeed in his mission for David and longterm vision thereafter, that detonated a Renaissance for mankind from which we still reap huge benefits. He carved David from a blocky first cut by his elders and was not solely self taught. He was a giant that created a giant by standing on the shoulders of giants funded by the boldest thinkers and investors of his era. This is much the same as in Biotechnology. If you are in the Biotech space, investing or building, and wondering how on Earth you can carve a meaningful change to the fossilised incentives and disease-dependent rule of the big blockbuster industry, in your lifetime, you can’t go wrong with the story of Michelango’s David in your mindset. The extraordinary poise, fluidity of posture, even if not moved in 5 centuries, those hands holding the simplest of weapons, and those eyes knowing exactly where and when to strike. This is how the Innovator prevails. This is how the Underdog wins. This is how #David beats #Goliath. 📸 by my iPhone